Potential dysregulation of the pyruvate dehydrogenase complex by bacterial toxins and insulin

Journal of Trauma - Injury, Infection and Critical Care

Volumn 67, Issue 3, 2009, Pages 628-633

  Thomas, Gregory W ^a,b,d   Mains, Charles W ^b   Slone, Denetta Sue ^c   Craun, Michael L ^e   Bar Or, David ^a,b,d  

^a SWEDISH MEDICAL CENTER   (United States)

^b St Anthony Central Hospital   (United States)

^c HealthOne   (United States)

^d DMI BioSciences   (United States)

^e SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Lipopolysaccaride; Lipoteichoic acid; Pyruvate dehydrogenase complex; Pyruvate dehydrogenase kinase; Pyruvate dehydrogenase phosphate phosphatase

Indexed keywords

AGAROSE; BACTERIAL TOXIN; DNA FRAGMENT; ETHIDIUM BROMIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INSULIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MESSENGER RNA; PYROXYLIN; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE PHOSPHATASE; PYRUVATE DEHYDROGENASE PHOSPHATASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; PROTEIN KINASE; PYRUVATE DEHYDROGENASE KINASE 4;

ARTICLE; DENSITOMETRY; ENZYME ACTIVITY; GENE AMPLIFICATION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HYPERLACTATEMIA; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; CULTURE TECHNIQUE; DRUG EFFECT; ENZYMOLOGY; GENETICS; LIVER CELL; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPOPOLYSACCHARIDES; LIVER NEOPLASMS; PROTEIN KINASES; PYRUVATE DEHYDROGENASE (LIPOAMIDE)-PHOSPHATASE; PYRUVATE DEHYDROGENASE COMPLEX; RNA, MESSENGER;

EID: 70449134237     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181a8b415     Document Type: Article

References (20)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348: 1546-1554.
3. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest. 2003;112:460-467.
4. Trzeciak S, Dellinger RP, Chansky ME, et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med. 2007;33:970-977.
5. Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996;171:221-226.
6. Gore DC, Jahoor F, Hibbert JM, DeMaria EJ. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg. 1996;224:97-102.
7. Sugden MC, Holness MJ. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab. 2003;284:E855-E862.
8. Lee FN, Zhang L, Zheng D, Choi WS, Youn JH. Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA. Am J Physiol Endocrinol Metab. 2004;287:E69-E74.
9. Vary TC. Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate. Shock. 1996; 6:89-94.
10. Vary TC, Hazen S. Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem. 1999;198:113-118.
11. Alamdari N, Constantin-Teodosiu D, Murton AJ, et al. Temporal changes in the involvement of pyruvate dehydrogenase complex in muscle lactate accumulation during lipopolysaccharide infusion in rats. J Physiol. 2008;586:1767-1775.
12. De Backer D. Lactic acidosis. Minerva Anestesiol. 2003;69:281-284. (Pubitemid 41750914)
13. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
14. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
15. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.
16. Bundgaard H, Kjeldsen K, Suarez Krabbe K, et al. Endotoxemia stimulates skeletal muscle Na+-K+-ATPase and raises blood lactate under aerobic conditions in humans. Am J Physiol Heart Circ Physiol. 2003; 284:H1028-H1034.
17. James JH, Wagner KR, King JK, et al. Stimulation of both aerobic glycolysis and Na(+)-K(+)-ATPase activity in skeletal muscle by epinephrine or amylin. Am J Physiol. 1999;277:E176-E186.
18. Vary TC, Hazen SA, Maish G, Cooney RN. TNF binding protein prevents hyperlactatemia and inactivation of PDH complex in skeletal muscle during sepsis. J Surg Res. 1998;80:44-51.
19. Vary TC, O'Neill P, Cooney RN, Maish G III, Shumate M. Chronic infusion of interleukin 1 induces hyperlactatemia and altered regulation of lactate metabolism in skeletal muscle. JPEN J Parenter Enteral Nutr. 1999;23:213-217.
20. Severin PN, Uhing MR, Beno DW, Kimura RE. Endotoxin-induced hyperlactatemia results from decreased lactate clearance in hemodynamically stable rats. Crit Care Med. 2002;30:2509-2514.